Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Zamboni

Showing results (1-10 of 180) with videos related to

Pageof 18
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2005
Liposomal, nanoparticle, and conjugated formulations of anticancer agentsWilliam C Zamboni
Pharmacotherapy|August 19, 2003
Pharmacokinetics of pegfilgrastimWilliam C Zamboni
The Oncologist|April 2, 2008
Concept and clinical evaluation of carrier-mediated anticancer agentsWilliam C Zamboni
Clinical Pharmacokinetics|April 1, 1997
Pharmacokinetic optimisation of cancer chemotherapy. Effect on outcomesE Masson, W C Zamboni
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|May 10, 2002
Cellular, pharmacokinetic, and pharmacodynamic aspects of response to camptothecins: can we improve it?L L Jung, W C Zamboni
Annali Sclavo; Rivista Di Microbiologia E Di Immunologia|January 1, 1980
[Microbial contamination of hospital departments]A Lazzara, G Stassi, C Zamboni
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|January 5, 2002
Cellular, pharmacokinetic, and pharmacodynamic aspects of response to camptothecins: can we improve it?L L Jung, W C Zamboni
Giornale Italiano Di Chemioterapia|January 1, 1977
[Inducibility of 1-step and multi-step resistance in Staphylococcus aureus strains]V Cusumano, A Focà, C Zamboni
Pharmacotherapy|September 12, 2002
An overview of the pharmacokinetic disposition of darbepoetin alfaWilliam C Zamboni, Clinton E Stewart
Giornale Italiano Di Chemioterapia|January 1, 1977
[The antimycotic activity of pentamycin]V Cusumano, C Zamboni, M S Leonardi
Pageof 18

Showing results (1-10 of 180) with videos related to

Sort By:
Pageof 18
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2005
Liposomal, nanoparticle, and conjugated formulations of anticancer agentsWilliam C Zamboni
Pharmacotherapy|August 19, 2003
Pharmacokinetics of pegfilgrastimWilliam C Zamboni
The Oncologist|April 2, 2008
Concept and clinical evaluation of carrier-mediated anticancer agentsWilliam C Zamboni
Clinical Pharmacokinetics|April 1, 1997
Pharmacokinetic optimisation of cancer chemotherapy. Effect on outcomesE Masson, W C Zamboni
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|May 10, 2002
Cellular, pharmacokinetic, and pharmacodynamic aspects of response to camptothecins: can we improve it?L L Jung, W C Zamboni
Annali Sclavo; Rivista Di Microbiologia E Di Immunologia|January 1, 1980
[Microbial contamination of hospital departments]A Lazzara, G Stassi, C Zamboni
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|January 5, 2002
Cellular, pharmacokinetic, and pharmacodynamic aspects of response to camptothecins: can we improve it?L L Jung, W C Zamboni
Giornale Italiano Di Chemioterapia|January 1, 1977
[Inducibility of 1-step and multi-step resistance in Staphylococcus aureus strains]V Cusumano, A Focà, C Zamboni
Pharmacotherapy|September 12, 2002
An overview of the pharmacokinetic disposition of darbepoetin alfaWilliam C Zamboni, Clinton E Stewart
Giornale Italiano Di Chemioterapia|January 1, 1977
[The antimycotic activity of pentamycin]V Cusumano, C Zamboni, M S Leonardi
Pageof 18